Gamgee YC 申请

Summer 2026Active

San Francisco

Gamgee 在 Summer 2026 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。

YC 批次: Summer 2026
行业: HealthcareDrug Discovery and Delivery
地点: San Francisco
团队规模: 2
状态: Active
已发布: 2026

创始人

Paul ConynghamFounder/CEO

Gamgee 做什么

Gamgee began with Rosie, founder Paul Conyngham’s dog. After surgery, chemotherapy and immunotherapy failed, Rosie was given months to live. Paul used AI and genomic analysis to identify targets in her tumour, then worked with scientists at UNSW to produce what is believed to be the first fully computationally designed mRNA cancer vaccine delivered to a dog. Following treatment, several tumours shrank significantly and her quality of life improved Gamgee is building an end to end platform for personalised mRNA cancer vaccines for dogs. We sequence a dog’s tumour and healthy DNA, identify mutations unique to its cancer, and design a vaccine that teaches the immune system what to attack. We manage the entire process- from vet intake and tissue collection through genomic analysis, vaccine production, treatment and response monitoring We are now turning that one off effort into a repeatable clinical system. Gamgee is running clinical trials in Australia, working with vets, oncologists and specialised laboratories, and accepting cases globally. Our goal is to make personalised cancer treatment accessible to every dog that needs it- and use each case to improve the treatment for the next

Gamgee 的 YC 申请，重建版

Y Combinator 申请

Gamgee，Summer 2026 期。来自公开数据的真实申请问题解答。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Gamgee

Describe what your company does in 50 characters or less.

Personalised mRNA cancer vaccines for dogs.

What is your company going to make? Please describe your product and what it does or will do.

We're building an end-to-end platform for personalised mRNA cancer vaccines for dogs. We start by sequencing a dog's tumour and normal tissue, then use AI to identify and rank tumour-specific mutations. Our platform designs a custom mRNA vaccine targeting these mutations, coordinates production, and works with vets to oversee treatment and monitor outcomes.

Where do you live now, and where would the company be based after YC?

San Francisco, CA, USA; Remote. The company would remain based there after YC.

Explain your decision regarding location.

San Francisco connects us to both biotech resources and the YC ecosystem. We operate remotely to collaborate with labs, vets, and trial sites in Australia and globally.

21 更多回答在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。

查看完整申请

常见问题解答

这是 Gamgee 的真实 YC 申请吗？

不是。Y Combinator 对提交的申请保密。这是重建版：使用 Gamgee 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 Gamgee 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。

Gamgee 是哪个 YC 批次的？

Gamgee 是 Y Combinator Summer 2026 批次的成员。

谁创立了 Gamgee？

Gamgee 由 Paul Conyngham 创立。

Gamgee 做什么？

Curing cancer. Starting with dogs.

如何阅读完整的重建申请？

创建免费的 Round Funded 账户。YC Insights 中包含 Gamgee 的完整 26 个问题的版本，以及其他所有 YC 批次的公司信息。